comparemela.com

Latest Breaking News On - Contract development manufacturing organization - Page 9 : comparemela.com

Liminal BioSciences Reports First Quarter Financial Results 2023

GPR84 antagonist program and OXER1 antagonist program on track to meet previously stated milestones in 2023Closed March 31, 2023 with just over CAD26.9 million cash on hand, expecting to provide. | June 16, 2023

United kingdomBruce pritchardLiminal biosciences incExchange commissionContract development manufacturing organizationSecurities exchangeChief executive officerQuarter ended marchContract development manufacturingSecurities actSecurities exchange actLiminal bioscienceNasdaq listing ruleNasdaq capital marketCanadian securities administratorsAnnual report

PolyPeptide announces results of the annual General Meeting 2023

PolyPeptide Group / Key word: AGMEGM PolyPeptide announces results of the annual General Meeting 2023 12.04.2023 / 19:18 CET/CEST Media Release PolyPeptide announces. | April 12, 2023

Chollerhalle zugPeter wildenPhilippe weberDorotheea deuringNomination committeeContract development manufacturing organizationHead of investor relations corporate communicationsArticles of associationPolypeptide groupSwiss exchangeGeneral meetingExecutive chairmanIndependent proxyStatutory auditorsExecutive committeeAnnual report

PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO

PolyPeptide Group / Key word(s): Personnel PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO 03-Apr-2023 / 07:0.

United statesUniversidad de limaFuhr millerPeter wildenLalit ahluwaliaAsia pacificJan fuhr millerPolypeptide groupBoard of directors polypeptide groupMckinsey coUniversity of notre dameHead of investor relations corporate communicationsSwiss exchangeMaster of business administrationProcter gambleFerring pharmaceuticals

Pros to Know: Leaders of the Pack in Diversity, Innovation and Technology

This year’s Pros to Know winners are leading the pack in terms of innovation, enhancement and providing problem-solving solutions to the supply chain.

South koreaUnited statesPuerto ricoKeith hartleyJason milbrandtKrystal jacksonLana burrellCarmit glikBill bentonJeff vaughnChristine barnhartNicole glennLindsey trentBrandon maruggDavid bushHannah kain

PolyPeptide reports weaker performance in 2022 expects growth to recover in the second half of 2023

PolyPeptide / Key word(s): Annual Results PolyPeptide reports weaker performance in 2022 expects growth to recover in the second half of 2023.

Louis pasteurJan fuhr millerPeter wildenDorotheea deuringPolypeptide results centerHead of investor relations corporate communicationsLonza groupPolypeptide group agsSwiss exchangeContract development manufacturing organizationMaster of business administrationPolypeptide groupPolypeptide group ags annualAxpo holdingPeptide groupExecutive chairman

vimarsana © 2020. All Rights Reserved.